Date: 11.2.2014
Technology offer: New specific biomarker for human prostate cancer prognosis
Reference: TOFR20131113002
Summary: An academic French laboratory developed a process based on detection of a microRNA (Ribonucleic acid molecule) as a molecular biomarker dedicated to the prognosis of cancers of the male reproductive system, including prostate cancer. This microRNA is flexible to use, non invasive and easily automatable and suitable for use on industrial scale. Industrial partners are sought for licence agreement or technical cooperation.
For more information click here.
Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Práce - Nabidky prace
Biotechnology company - list of biotechnology companies
USDA approves stunning bioluminescent firefly petunias for sale
Solar panels in your eyeballs: Self-powered bionics are on the way